PALATINE, Ill., March 15, 2007 (PRIME NEWSWIRE) (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $6.0 million or $0.08 per common share for calendar year 2006 compared to a net loss of $12.1 million or $0.18 per common share for calendar year 2005. For the quarter ended December 31, 2006 the Company had net income of $3.9 million with a loss of $0.04 per common share after special non-cash deemed dividends (as described below). This compares to a net loss of $7.1 million or $0.04 per common share for the same quarter in 2005.
